AACR Conference on the Microbiome, Viruses, and Cancer: How Gut Microbes Can Mediate Responses to Stem Cell Transplants
The first allogeneic hematopoietic-cell transplant (HCT) – a complex procedure where a patient receives blood stem cells isolated from a healthy donor – was performed in 1957. Now, over 9,000 allogeneic hematopoietic-cell transplants are performed per year in the United States. This type of transplant is generally used to treat patients with bone marrow disorders, including certain types of leukemia, lymphoma, and multiple myeloma.
